Why medication reviews are not the same as pharmacy reviews
Understanding the fundamental differences in scope, purpose, and framework between insurance medication reviews and standard pharmacy services
Published 3 April 2026
Introduction
Insurance professionals frequently confuse medication reviews with community pharmacy consultations, assuming they are interchangeable services. This confusion can lead to underutilisation of review services or false confidence that standard pharmacy consultations adequately address insurance-specific medication concerns. In reality, insurance medication reviews and pharmacy consultations operate in entirely different frameworks with distinct purposes, scopes, and deliverables.
Understanding these differences is essential for insurers to appropriately utilise medication review services and to set accurate expectations for review outcomes and claim management value.
Definitional Differences
Pharmacy Review (Standard Healthcare Model)
A pharmacy review, conducted by community or hospital pharmacists, focuses on medication safety and appropriateness within standard healthcare context. The pharmacist reviews medications dispensed through their pharmacy, assesses for drug interactions, side effects, and adherence support, and refers concerns to prescribing physicians. Review purpose is to ensure medications are being taken correctly and safely within the patient's healthcare framework.
Scope: medications currently dispensed, current symptoms and adherence, identification of interaction and safety concerns. Deliverable: advice to patient and/or referral to physician regarding medication management adjustments.
Medication Review (Insurance Context)
An insurance medication review, conducted by specialist insurance pharmacists, focuses on cost impact, claim appropriateness, functional outcome relationship, and claim management strategy. The reviewer assesses entire medication history, analyses cost implications, evaluates whether medications are supporting claim recovery or impeding it, and provides recommendations for claim management including deprescribing strategies, cost containment, and functional outcome optimisation.
Scope: full medication history (not just current dispensing), historical medication patterns, cost analysis, functional outcome assessment, claim management context. Deliverable: insurer-focused report with recommendations for claim management strategy, cost containment, and outcome optimisation.
Contextual and Purpose Differences
| Dimension | Pharmacy Review | Insurance Medication Review |
|---|---|---|
| Primary purpose | Medication safety and adherence in healthcare | Cost management and claim outcome optimisation |
| Client focus | Patient (claimant) | Insurer and claim manager |
| Scope | Medications currently dispensed locally | Full medication history across all prescribers and pharmacies |
| Time horizon | Current medication status, immediate issues | Full claim history, prospective cost forecasting |
| Primary concern | Is medication safe and appropriate? | Is medication cost-effective and supporting claim recovery? |
| Recommendation type | Safety adjustments, adherence counselling | Cost containment, deprescribing, functional outcome strategy |
| Accountability | To patient and patient's physicians | To insurer and claim manager |
Scope and Information Access Differences
Pharmacy Review Limitations
Community pharmacists see only medications dispensed through their pharmacy. They do not typically see: medications dispensed at other pharmacies, medications obtained privately without pharmacy claims submission, previous medications no longer being dispensed, prescriber communications, clinical assessment notes, or historical medication patterns. This information fragmentation means pharmacy reviews address only visible portion of medication regimen.
For insurance claims where claimants often see multiple prescribers and obtain medications across multiple pharmacies, pharmacy review information is necessarily incomplete.
Insurance Review Comprehensive Access
Insurance medication reviews have access to complete medication history from claim documentation, pharmacy records obtained through release of information, prescriber notes, hospital discharge summaries, and real-time prescription monitoring data (where available). Reviewers can assess full trajectory of medication regimen from claim initiation through current status, identifying patterns and cost drivers not visible in single-pharmacy view.
Analytical Framework Differences
Pharmacy Review Analysis
Pharmacy reviews employ standard pharmaceutical care framework: assess indication appropriateness, evaluate dosing, identify drug interactions and contraindications, assess adherence, review side effects. Analysis focuses on pharmaceutical safety questions: Is this medication appropriate? Is dose safe? Are there interactions? Is patient taking it correctly?
Insurance Review Analysis
Insurance reviews employ insurance-specific analytical framework: assess cost-benefit for claim (does benefit justify cost?), evaluate trajectory (is regimen stabilising or escalating?), analyse functional relationship (is medication supporting return-to-work or impeding it?), assess deprescribing feasibility, evaluate cost containment opportunities, forecast long-term cost impacts.
Insurance analysis adds dimensions absent from standard pharmacy review: cost per unit of benefit, claim duration projections, functional outcome correlation, deprescribing timelines, and claim management strategy implications.
Practical Example: Same Medications, Different Reviews
Consider a claimant on chronic opioids (oxycodone 30mg three times daily) for pain management.
Pharmacy Review Findings: Appropriate indication (chronic pain), appropriate dose (within standard dosing range), side effects noted (constipation, sedation), managed with adjunctive medications (laxatives, caffeine). Assessment: Pharmacy review concludes medication is appropriately prescribed and patient is receiving appropriate side effect management. Recommendation: Continue current regimen, reinforce adherence, monitor for ongoing appropriateness.
Insurance Review Findings: Opioid therapy beyond 90 days in workers compensation without evidence of pain reduction or functional improvement. Dose escalation trend observed (started at 20mg, now at 30mg, projected 40mg in 6 months). Side effect burden substantial (constipation requiring multiple agents, sedation affecting work participation). Cost: opioid AUD 60/month, adjunctive medications AUD 50/month, specialist monitoring AUD 200/month, estimated productivity loss AUD 1,000/month. Functional outcome analysis: pain inadequately controlled despite dose escalation; return-to-work delayed 8 weeks compared to similar claimants on non-opioid pain management. Assessment: Opioid therapy not cost-effective and impeding functional recovery. Recommendation: Initiate structured opioid deprescribing, transition to multimodal non-opioid pain management (physiotherapy, psychological pain management, non-opioid pharmacotherapy), implement 12-week deprescribing timeline with functional outcome monitoring.
Same medications, entirely different conclusions and recommendations, because reviews operate within different analytical frameworks and purposes.
Independence and Accountability Differences
Pharmacy Review Constraints
Community pharmacists are accountable to their employer (pharmacy owner/manager), patients, and prescribers. Making recommendations contrary to current prescriber practice or suggesting medication cessation can create professional tension. Pharmacy reviews often diplomatically suggest "discussing with prescriber" rather than directly recommending medication change, particularly for medications prescribed by powerful specialists.
Additionally, if pharmacy is for-profit entity dispensing the medications under review, financial incentive exists to continue medication dispensing rather than recommend deprescribing. This creates conflict of interest, even if inadvertent.
Insurance Review Independence
Insurance medication reviewers are accountable to insurer and claims manager, with explicit charge to optimise claim outcomes and manage costs. No financial incentive exists to continue medication dispensing. Recommendations can be direct and specific: "deprescribe this medication", "this indication is not supported by evidence", "transition to alternative agent", without concern for offending prescribers. Independence enables more assertive claim management recommendations.
Output and Actionability Differences
Pharmacy Review Output
Pharmacy reviews typically produce brief written summary or verbal consultation with patient. Recommendation: general guidance ("discuss with doctor about reducing dose", "avoid alcohol with medication"). Output is patient-focused and generally non-directive regarding medication changes.
Insurance Review Output
Insurance reviews produce detailed written report for claim manager including: medication history analysis, cost impact analysis, functional outcome assessment, clinical recommendations with specific timeline and rationale, deprescribing protocols if applicable, and claim management strategy. Output is insurer-focused and provides specific action items and decision support for claim management.
When Pharmacy Reviews Are Appropriate
Standard pharmacy reviews are valuable for: adherence counselling, side effect management at point of dispensing, identification of basic drug interactions, patient education regarding medication use, and reinforcement of prescriber recommendations. Pharmacy reviews are NOT appropriate substitutes for insurance medication reviews.
Scenarios Where Pharmacy Review is Insufficient
- Claims with complex polypharmacy (5+ medications)
- Claims with multiple prescribers/pharmacies
- Claims with medication cost escalation concerns
- Claims with unclear functional outcome relationship to medications
- Claims requiring deprescribing strategy
- Claims with medication-induced adverse events
- Claims with cost forecasting or budget planning needs
Integrated Approach: Combining Both Services
Optimal medication management in insurance claims employs both services in complementary roles. Pharmacy review provides ongoing patient-facing medication safety and adherence support. Insurance medication review provides claim manager with strategic medication management guidance and cost optimisation recommendations. When pharmacy review identifies concerns (non-adherence, adverse effects), these can be referred for insurance review to assess whether underlying medication regimen change is warranted.
Conclusion
Insurance medication reviews and standard pharmacy reviews are fundamentally different services serving different purposes in different contexts. Pharmacy reviews provide important patient-facing medication safety support. Insurance reviews provide insurer-focused claim management guidance and cost optimisation strategies. Insurers should not regard pharmacy review as substitute for insurance medication review, and should utilise both services in their distinct and complementary roles to optimise both patient safety and claim management outcomes.
Does your claim need specialist medication review or patient-facing pharmacy consultation?
IMM provides specialist insurance medication reviews designed for claim managers. Our reviews deliver claim management strategy, cost analysis, and functional outcome recommendations. Refer to your claimant's community pharmacist for ongoing medication safety counselling; refer to IMM for claim management medication strategy.
Request a Medication Review
